SEARCH

SEARCH BY CITATION

References

  • 1
    Centers for Disease Control and Prevention (CDC) [ Weinbaum CM, Williams I, Mast EE, Wang SA et al]. Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR Recomm Rep 2008; 57: 1-20.
  • 2
    Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006; 144: 705-714.
  • 3
    Institute of Medicine (IOM). Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C. Washington, DC: The National Academies Press; 2010. Available at: http://www.nap.edu/catalog.php?record_id=12793#toc. Accessed on March 15, 2012.
  • 4
    Centers for Disease Control and Prevention (CDC). Viral hepatitis surveillance—United States, 2009. Available at: http://www.cdc.gov/hepatitis/Statistics/2009Surveillance/index.htm. Accessed on March 15, 2012.
  • 5
    United States Department of Health and Human Services. Combating the silent epidemic of viral hepatitis: action plan for the prevention, care and treatment of viral hepatitis. 2011. Available at: http://www.hhs.gov/ash/initiatives/hepatitis. Accessed on March 15, 2012.
  • 6
    Centers for Disease Control and Prevention (CDC). Evaluation of acute hepatitis C infection surveillance—United States, 2008. MMWR Morb Mortal Wkly Rep 2010;59:1407-1410. Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5943a3.htm?s_cid=mm5943a3_w. Accessed on March 15, 2012.
  • 7
    Centers for Disease Control and Prevention (CDC). Surveillance for acute viral hepatitis—United States, 2007. MMWR Morb Mortal Wkly Rep 2009;58. Available at: www.cdc.gov/mmwr/pdf/ss/ss5803.pdf. Accessed on March 15, 2012.
  • 8
    Alter MJ, Hadler SC, Judson FN, Mares A, Alexander WJ, Hu PY, et al. Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. JAMA 1990; 264: 2231-2235.
  • 9
    Williams IT, Perz JF, Bell BP. Viral hepatitis transmission in ambulatory health care settings. Clin Infect Dis 2004; 38: 1592-1598.
  • 10
    Thompson ND, Perz JF, Moorman AC, Holmberg SD. Nonhospital health care-associated hepatitis B and C virus transmission: United States, 1998-2008. Ann Intern Med 2009; 150: 33-39.
  • 11
    Williams IT, Bell BP, Kuhnert W, Alter MJ. Incidence and transmission patterns of acute hepatitis C in the United States, 1982-2006. Arch Intern Med 2011; 17: 242-248.
  • 12
    Perz JF, Thompson ND, Schaefer MK, Patel P. U.S. outbreak investigations highlight the need for safe injection practices and basic infection control. Clin Liver Dis 2010; 14: 137-151. Available at http://www.liver.theclinics.com/article/S1089-3261(09)00085-3/abstract.
  • 13
    Schappert SM, Rechtsteiner EA. Ambulatory medical care utilization estimates for 2006. In: National Health Statistics Reports; no 8. Hyattsville, MD: National Center for Health Statistics; 2008.
  • 14
    Centers for Disease Control and Prevention (CDC). Case definition: acute hepatitis B (2000). Atlanta, GA: US Department of Health and Human Services, CDC; 2000. Available at: http://www.cdc.gov/osels/ph_surveillance/nndss/casedef/hepatitisb2000.htm. Accessed on March 16, 2012.
  • 15
    Centers for Disease Control and Prevention (CDC). Case definition: acute hepatitis C (2004). Atlanta, GA: US Department of Health and Human Services, CDC; 2004. Available at: http://www.cdc.gov/osels/ph_surveillance/nndss/casedef/hepatitiscacute2004.htm. Accessed on March 16, 2012.
  • 16
    Fleiss JL. Statistical Methods for Rates and Proportions, Second Ed. New York, NY: John Wiley & Sons; 1981.
  • 17
    Bruzzi P, Green SB, Byar DP, Brinton LA, Schairer C. Estimating the population attributable risk for multiple risk factors using case-control data. Am J Epidem 1985; 122: 904-914.
  • 18
    United States Census Bureau. Age: 2000, Census 2000 Brief. 2001. Available at: http://www.census.gov/prod/2001pubs/c2kbr01–12.pdf. Accessed on March 16, 2012.
  • 19
    Fischer GE, Schaefer MK, Labus B, Sands L, Rowley P, Azzam IA, et al. Hepatitis C virus infections from unsafe injection practices at an endoscopy clinic in Las Vegas, Nevada, 2007-2008. Clin Inf Dis 2010; 51: 267-273.
  • 20
    Gutelius B, Perz JF, Parker MM, Hallack R, Stricof R, Clement EJ, et al. Multiple clusters of hepatitis virus infections associated with anesthesia for outpatient endoscopy procedures: New York City, 2005-2006. Gastroenterology 2010; 139: 163-170.
  • 21
    Greeley RD, Semple S, Thompson ND, High P, Rudowski E, Handschur E, et al. Hepatitis B outbreak associated with a hematology-oncology office practice in New Jersey, 2009. Am J Infect Control 2011; 39: 663-670.
  • 22
    Moore ZS, Schaefer MK, Hoffmann KK, Thompson SC, Xia GL, Lin Y, et al. Transmission of hepatitis C virus during myocardial perfusion imaging in an outpatient clinic. Am J Cardiol 2011; 108: 126-132.
  • 23
    Centers for Disease Control and Prevention (CDC). Viral hepatitis case report forms. Available at: http://www.cdc.gov/hepatitis/PDFs/vhsp02.pdf. Accessed on March 17, 2012.
  • 24
    Allos BM, Schaffner W. Transmission of hepatitis B in the health care setting: the elephant in the room, or the mouse? J Infect Dis 2007; 195: 1245-1247.
  • 25
    Wang CC, Krantz A, Klarquist J, Krows M, McBride L, Scott EP, et al. Acute hepatitis C in a contemporary US cohort: modes of acquisition and factors influencing viral clearance. J Infect Dis 2007; 196: 1474-1482.
  • 26
    Cherry DK, Hing E, Woodwell DA, Rechtsteiner EA. National Ambulatory Medical Care Survey: 2006 summary. In: National Health Statistics Reports; no 3. Hyattsville, MD: National Center for Health Statistics; 2008.
  • 27
    Schaefer MK, Jhung M, Dahl M, Schillie S, Simpson C, Llata E, et al. Infection control assessment of ambulatory surgical centers. JAMA 2010; 303: 2273-2279.
  • 28
    Tsui JI, Maselli J, Gonzales R. Sociodemographic trends in national ambulatory care visits for hepatitis C virus infection. Dig Dis Sci 2009; 54: 2694-2698.
  • 29
    Hellinger WC, Bacalis LP, Kay RS, Thompson ND, Xia GL, Lin Y, et al. Health care–associated hepatitis C virus infections attributed to narcotic diversion. Ann Intern Med 2012; 156: 477-482.
  • 30
    Centers for Disease Control and Prevention (CDC). Guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings 2007. Atlanta, GA: US Department of Health and Human Services, CDC; 2007. Available at: http://www.cdc.gov/hicpac/2007IP/2007isolationPrecautions.html. Accessed on March 16, 2012.
  • 31
    Pugliese G, Gosnell C, Bartley JM, Robinson S. Injection practices among clinicians in United States health care settings. Am J Infect Control 2010; 38: 789-798.
  • 32
    Schaefer MK, Shehab N, Perz JF. Calling it ‘multidose’ doesn't make it so: inappropriate sharing and contamination of parenteral medication vials. Am J Infect Control 2010; 38: 580-581.
  • 33
    Maki DG, Crnich CJ. History forgotten is history relived: nosocomial infection control is also essential in the outpatient setting. Arch Intern Med 2005; 165: 2565-2567.
  • 34
    Alter M. Healthcare should not be a vehicle for transmission of hepatitis C virus. J Hepatol 2008; 48: 2-4.
  • 35
    Wenzel RP, Edmond MB. Patient-to-patient transmission of hepatitis C virus. Ann Intern Med 2005; 142: 940-941.
  • 36
    Premier Safety Institute. Safer designs for safer injections: innovations in process, products and practices. 2011. Available at: http://www. premierinc.com/quality-safety/tools-services/safety/topics/safe_injection_practices/meeting.jsp. Accessed on March 16, 2012.
  • 37
    Centers for Disease Control and Prevention (CDC). Recommendations for preventing transmission of infections among chronic hemodialysis patients. MMWR Morb Mortal Wkly Rep 2001; 50: 1-43.
  • 38
    Shimokura G, Chai F, Weber DJ, Samsa GP, Xia GL, Nainan OV, et al. Patient-care practices associated with an increased prevalence of hepatitis C virus infection among chronic hemodialysis patients. Infect Control Hosp Epidemiol 2011; 32: 415-424.
  • 39
    Centers for Disease Control and Prevention (CDC). Infection control requirements for dialysis facilities and clarification regarding guidance on parenteral medication vials. MMWR Morb Mortal Wkly Rep 2008; 57: 875-876.
  • 40
    Centers for Disease Control and Prevention (CDC). Hepatitis C virus transmission at an outpatient hemodialysis unit—New York, 2001-2008. MMWR Morb Mortal Wkly Rep 2009; 58: 189-194.
  • 41
    Thompson ND, Novak RT, Datta D, Cotter S, Arduino MJ, Patel PR, et al. Hepatitis C virus (HCV) transmission in the hemodialysis setting: the importance of infection control practices and aseptic technique. Infect Control Hosp Epidemiol 2009; 30: 900-903.
  • 42
    Centers for Disease Control and Prevention (CDC). Transmission of hepatitis B virus among persons undergoing blood glucose monitoring in long-term-care facilities—Mississippi, North Carolina, and Los Angeles County, California, 2003-2004. MMWR Morb Mortal Wkly Rep 2005; 54: 220-223.
  • 43
    Centers for Disease Control and Prevention (CDC). Notes from the field: deaths from acute hepatitis B virus infection associated with assisted blood glucose monitoring in an assisted living facility—North Carolina, August-October 2010. MMWR Morb Mortal Wkly Rep 2011; 60: 182.
  • 44
    Thompson ND, Schaefer MK. “Never events”: hepatitis B outbreaks and patient notifications resulting from unsafe practices during assisted monitoring of blood glucose, 2009-2010. J Diabetes Sci Technol 2011; 5: 1396-402.
  • 45
    Schaffzin JK, Southwick KL, Clement EJ, Konings F, Ganova-Raeva L, Xia G, et al. Transmission of hepatitis B virus associated with assisted monitoring of blood glucose at an assisted living facility in New York State. Am J Infect Control 2012 Jan 27. DOI: 10.1016/j.ajic.2011.11.002.